Seventy-three consecutive cases of childhood acute lymphoblastic leukemia (ALL) diagnosed and managed in Queen Mary Hospital over a 10-year period from 1985 to 1994 were retrospectively analysed for their presenting features and treatment outcome. The 48 boys and 25 girls ranged in age from 0β’4 to 1
Acute lymphoblastic leukemia and Down syndrome : Presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP)
β Scribed by Maurizio Arico; Ottavio Ziino; Maria Grazia Valsecchi; Giovanni Cazzaniga; Carlo Baronci; Chiara Messina; Andrea Pession; Nicola Santoro; Giuseppe Basso; Valentino Conter
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 235 KB
- Volume
- 113
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Childhood Bβcell lymphomas (BβNHLs) represent a group of aggressive malignancies that are amenable to highβintensity chemotherapy regimens. In 1992, the Italian Association of Pediatric Hematology and Oncology (AIEOP) initiated a prospective clinical trial involving the d
In this retrospective multicentric study, we report on early deaths (ie, those that occurred during the first month of treatment) in a total of 943 newly diagnosed ALL pediatric patients registered from 1976 to 1981 at 21 centers of the AlL-AIEOP. Objectives of this study were as follows: (1) to ver
## Abstract ## BACKGROUND. Children with Down syndrome (DS) have from 10 to 20 times the risk of developing acute leukemia than the general pediatric population. There is mixed evidence for associations between reproductive history or infertility and acute leukemia among children without DS. ## M